Sage Therapeutics Community
NasdaqGM:SAGE Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 7 Fair Values set on narratives written by author
Community Investing Ideas
AN
Consensus Narrative from 18 Analysts
Expanding ZURZUVAE Demand Will Improve Postpartum And Neuropsych Care
Key Takeaways Establishing ZURZUVAE as the PPD care standard should drive top-line growth through increased demand and brand visibility. Focus on neuropsych and neurodevelopmental disorders and strategic R&D could enhance long-term shareholder value and revenue potential.
View narrativeUS$8.05
FV
2.3% undervalued intrinsic discount66.13%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
4 days ago author updated this narrative